Literature DB >> 3094806

Fate in intermittent claudication: outcome and risk factors.

R Jelnes, O Gaardsting, K Hougaard Jensen, N Baekgaard, K H Tønnesen, T Schroeder.   

Abstract

The fate of 257 consecutive patients (100 women) aged 36-85 years (mean 65) first seen with intermittent claudication in 1977 was analysed after a mean of 6.5 (SD 0.5) years. When first seen none of the patients complained of rest pain or had ulcers or gangrenous lesions on the feet. At follow up 113 of the patients (44%) had died. Causes of death were no different from those in the general population. Mortality was twice that of the general population matched for age and sex. Mortality among the men was twice that among the women. In men under 60 mortality was four times that expected. The rate of clinical progression of the arteriosclerotic disease (that is, rest pain or gangrene) of the worst affected leg was 7.5% in the first year after referral. Thereafter the rate was 2.2% a year. An ankle systolic blood pressure below 70 mm Hg, a toe systolic blood pressure below 40 mm Hg, or an ankle/arm pressure index below 50% were individually significantly associated with progression of the arteriosclerotic disease. These findings show the importance of peripheral blood pressure measurements in the management of patients with intermittent claudication due to arteriosclerotic disease.

Entities:  

Mesh:

Year:  1986        PMID: 3094806      PMCID: PMC1341850          DOI: 10.1136/bmj.293.6555.1137

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  18 in total

1.  Intermittent claudication: its natural course.

Authors:  A M Imparato; G E Kim; T Davidson; J G Crowley
Journal:  Surgery       Date:  1975-12       Impact factor: 3.982

2.  Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors.

Authors:  J L JUERGENS; N W BARKER; E A HINES
Journal:  Circulation       Date:  1960-02       Impact factor: 29.690

3.  Effect of daily muscular exercise in patients with intermittent claudication.

Authors:  O A Larsen; N A Lassen
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

4.  The Framingham Study. Cigarettes and the development of intermittent claudication.

Authors:  W B Kannel; D Shurtleff
Journal:  Geriatrics       Date:  1973-02

5.  Some factors influencing the spontaneous course of arterial vascular insufficiency.

Authors:  F R Mathiesen; E E Larsen; M Wulff
Journal:  Acta Chir Scand       Date:  1970

6.  Intermittent claudication: factors determining outcome.

Authors:  W G Hughson; J I Mann; D J Tibbs; H F Woods; I Walton
Journal:  Br Med J       Date:  1978-05-27

7.  Intermittent claudication: prevalence and risk factors.

Authors:  W G Hughson; J I Mann; A Garrod
Journal:  Br Med J       Date:  1978-05-27

8.  The fate of patients with intermittent claudication managed nonoperatively.

Authors:  F F McAllister
Journal:  Am J Surg       Date:  1976-11       Impact factor: 2.565

9.  Healing of ulcers on the feet correlated with distal blood pressure measurements in occlusive arterial disease.

Authors:  P Holstein; N A Lassen
Journal:  Acta Orthop Scand       Date:  1980-12

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  32 in total

Review 1.  Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Authors:  Ezequiel Balmori Melian; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Current strategies in the diagnosis and management of lower extremity peripheral vascular disease.

Authors:  T J Wilt
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

3.  A single bout of resistance exercise does not modify cardiovascular responses during daily activities in patients with peripheral artery disease.

Authors:  Lausanne B C C Rodrigues; Cláudia L M Forjaz; Aluísio H R A Lima; Alessandra S Miranda; Sérgio L C Rodrigues; Crivaldo G Cardoso; Dario Sobral Filho; Maria F Monteiro; Silvana L Gomes; Andrew W Gardner; Wagner L Prado; Raphael M Ritti-Dias
Journal:  Blood Press Monit       Date:  2014-04       Impact factor: 1.444

Review 4.  Clinical Assessment of Peripheral Arterial Disease in the Office: What Do the Guidelines Say?

Authors:  Srini Tummala; Derek Scherbel
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

Review 5.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

6.  Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication: a prospective randomized controlled study with 1-year follow-up.

Authors:  Konstantinos T Delis; Andrew N Nicolaides
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

7.  Medical cost savings from pentoxifylline therapy in chronic occlusive arterial disease.

Authors:  K Neels; S Finkelstein; C Douglass
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

Review 8.  Evidence-based management of peripheral vascular disease.

Authors:  Nicolas W Shammas; Eric J Dippel
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

9.  Dual roles of tumor necrosis factor-alpha receptor-1 in a mouse model of hindlimb ischemia.

Authors:  Jun Jiang; Jianan Wang; Changling Li; Shan Ping Yu; Ling Wei
Journal:  Vasc Med       Date:  2009-02       Impact factor: 3.239

10.  Long-term survival after initial hospital admission for peripheral arterial disease in the lower extremities.

Authors:  I Vaartjes; G J de Borst; J B Reitsma; A de Bruin; F L Moll; D E Grobbee; M L Bots
Journal:  BMC Cardiovasc Disord       Date:  2009-08-28       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.